Post

Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation

US Senator Bernie Sanders has ramped up the pressure on Novo Nordisk after launching an investigation into GLP-1 agonist prices …

Erasca trims workforce and pipeline to focus on KRAS and molecular glues

Erasca has announced a shakeup of its clinical pipeline, shutting down three clinical programmes and licensing two cancer therapies from …

Galapagos enters deal to boost decentralised CAR-T therapy production

Galapagos has signed a strategic partnership with Blood Centers of America (BCA) to expedite the decentralised production of its chimeric …

FDA grants breakthrough therapy status for Nuvalent’s NVL-655

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) for Nuvalent’s brain-penetrant anaplastic lymphoma kinase (ALK)-selective …

CinDome Pharma secures $40m to advance gastroparesis treatment

CinDome Pharma has secured $40m in a Series B financing extension round aimed at progressing the development of deudomperidone (CIN-102) …